Investigación
Mayo Clinic doctors and scientists in the David F. and Margaret T. Grohne Cancer Immunology and Immunotherapeutics Research Program are pursuing cutting-edge research to better understand the interaction between the immune system and cancer cells.
Mayo Clinic doctors are actively conducting clinical trials to develop new ways of using bispecific antibodies to treat cancers. This includes combining bispecific antibodies with other powerful therapies and replacing traditional therapies with newer bispecific antibody-based therapies.
Cancer research is conducted in coordination with Mayo Clinic Comprehensive Cancer Center. Mayo Clinic Comprehensive Cancer Center receives funding from the National Cancer Institute and is designated as a comprehensive cancer center. This designation recognizes the institution's scientific excellence and multidisciplinary resources focused on cancer prevention, diagnosis and treatment.
Publications
See a list of publications about bispecific antibody therapy by Mayo Clinic doctors on PubMed, a service of the National Library of Medicine.